Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab [Phase 2]
A Phase 2 trial evaluating Ozurdex as an adjunct to ranibizumab for wet age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Non-exudative Age-related Macular Degeneration
This clinical trial update reports the completion of a study on non-exudative age-related macular degeneration conducted by Oregon Health an…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating RXI-109 to reduce progression of subretinal fibrosis in neovascular age-re…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Proton Radiation Therapy for Macular Degeneration [NA]
The proton radiation therapy trial for age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD [Phase 2]
Phase 2 trial evaluating sirolimus in combination with Eylea versus Eylea alone for exudative age-related macular degeneration has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia [Phase 4]
Phase 4 trial updating SD-OCT-guided intravitreal ranibizumab treatment for choroidal neovascularization due to myopia and age-related macul…
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases [Phase 1, Phase 2]
Clinical trial update on subretinal transplantation of retinal pigment epitheliums for dry age-related macular degeneration (Phase 1/Phase 2…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases [Phase 1, Phase 2]
Phase 1/2 clinical study evaluating subretinal transplantation of human embryonic stem cell-derived retinal pigment epithelium for macular d…
-
CLINICAL_TRIALS trial_result · 2018-01-08Clinical Trial Update: Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration [Phase 2]
Phase 2 dose-ranging study of pazopanib for neovascular age-related macular degeneration has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-08Clinical Trial Update: Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD [Phase 4]
Phase 4 trial update evaluating time course of activity signs at high-frequency intravitreal ranibizumab for CNV due to age-related macular …
-
CLINICAL_TRIALS trial_result · 2017-12-26Clinical Trial Update: Assessment of Psychological Strain and Perioperative Fear in Intravitreal Injections [Phase 2]
Phase 2 trial update evaluating psychological strain and perioperative fear related to intravitreal injections in age-related macular degene…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection) [Phase 4]
Phase 4 trial evaluating best corrected visual acuity in AMD patients treated with intravitreal aflibercept (VEGF Trap-Eye).
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating ALG-1001 for safety and efficacy in wet age-related macular degeneration has been completed.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]
This clinical trial update notes the completion of Phase 1/2 studies evaluating Combretastatin A4 Phosphate in patients with neovascular age…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: An Extension to Study MD7108240 [Phase 2]
An extension of the Phase 2 study MD7108240 for macular degeneration by GlaxoSmithKline has completed, with results posted on 2017-12-05.
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Head to Head Study of Anti-VEGF Treatment. [Phase 4]
Phase 4 head-to-head trial of anti-VEGF treatment for age-related macular degeneration completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept
Completed clinical trial update reporting genetic analyses of age-related macular degeneration patients who responded to ranibizumab but wer…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration [Phase 2]
Phase 2 proof-of-concept study of LHA510 as maintenance therapy for wet age-related macular degeneration has completed. Results were posted …
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans [Phase 1]
Phase 1 safety and pharmacokinetic study in healthy volunteers sponsored by GlaxoSmithKline to evaluate safety, absorption, and side effects…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers [Phase 1]
Phase 1 safety study of pazopanib eye drops in healthy volunteers has completed. The trial pertained to ocular use in the context of age-rel…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops [Phase 1]
Phase 1 pharmacokinetic study assessing the effect of repeat dosing with ketoconazole on pazopanib eye drops in patients with macular degene…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration [Phase 1]
The document reports the completion of a Phase 1 study evaluating pazopanib tablets in patients with neovascular age-related macular degener…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal
A completed clinical trial evaluating the five-year incidence of age-related macular degeneration in the central region of Portugal. The doc…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes
A completed clinical trial evaluating the use of teleophthalmology to address age-related macular degeneration and improve patient access an…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD [Phase 1]
A Phase 1 trial evaluating the safety, pharmacokinetics and pharmacodynamics of OPT-302 with or without Lucentis in patients with wet age-re…